Dynabeads™ CaptureSelect™ AAV9 Magnetic Beads
Dynabeads™ CaptureSelect™ AAV9 Magnetic Beads
Thermo Scientific™

Dynabeads™ CaptureSelect™ AAV9 Magnetic Beads

Thermo Scientific™ Dynabeads™ CaptureSelect™ AAV9 Magnetic Beads are high-capacity, high-throughput magnetic affinity particles for the purification of naturally occurring and synthetic adeno-associated virus serotype 9 (AAV9) used for gene therapy applications.
Have Questions?
Change viewbuttonViewtableView
Catalog NumberCapacity (Metric)
28533320011 mL
28533320055 mL
285333205050 mL
Catalog number 2853332001
Price (USD)/ Each
544.00
-
Add to cart
Capacity (Metric):
1 mL
Price (USD)/ Each
544.00
Add to cart
Dynabeads™ CaptureSelect™ AAV9 Magnetic Beads
Catalog number2853332001
Price (USD)/ Each
544.00
-
Add to cart

Dynabeads CaptureSelect AAV9 Magnetic Beads are high-capacity, high-throughput magnetic affinity particles for the purification of naturally occurring and synthetic adeno-associated virus serotype 9 (AAV9) used for gene therapy applications. The anti-AAV9 affinity ligand demonstrates good binding reactivity towards the AAV9 serotype. The magnetic beads enable purification using manual and robotic magnetic separators of the AAV9 serotype directly from crude feedstock in a single step with high purity and yield.

Features of DynaBeads CaptureSelect AAV9 Magnetic Beads include:

  • One-magnetic-step AAV purification from crude material with high purity and yield
  • Compatible with manual and automated workflows
  • High specificity and capacity
  • Easy upscaling to higher volumes
  • Non-animal derived

The magnetic beads bind with high affinity specifically to the AAV9 serotype. For the isolation of other AAV serotype capsids we recommend DynaBeads CaptureSelect AAVX magnetic beads (Cat. No. 2853522001, 2853522005, 2853522050).

Animal origin statement

CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a ∼12–15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain. The ligand is efficiently produced in yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).

Main characteristics

  • Bead matrix: non-porous monodisperse superparamagnetic beads
  • Bead size: 4.5 μm
  • Ligand: CaptureSelect AAV9 affinity ligand
  • Binding capacity: >5 x 1011 viral particles/mg beads
  • Elution conditions: 50 mM citric acid, pH 2.5–3.0
  • Formulation buffer: tris-buffered saline, 0.05% Tween 20, 0.05 % sodium azide
Specifications
Binding Capacity>0.5 x 1011 vp/mg beads
Capacity (Metric)1 mL
Concentration30 mg beads/mL slurry, 1 mg contains approximately 1.3 x 107 beads
Formulation4 to 6% (v/v) Slurry
MatrixNon-porous monodisperse superparamagnetic beads
Particle Size4.5 μm
Product LineCaptureSelect™
Quantity1 mL
For Use With (Application)Magnetic isolation of AAV9 capsids
TargetAAV9 (Adeno-associated serotype 9)
Ligand TypeCaptureSelect™ AAV9 Affinity Ligand
Unit SizeEach